NLA Clinical Recommendations Page 1 | Page 3 | National Lipid Association Online

NLA Statement on the IMPROVE-IT Study Findings: Results Support the NLA Recommendations that Lower Is Better

On June 3, 2015, the anticipated final results of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) was published online in the New England Journal of Medicine (NEJM 2015;372:2387-97).

2014 Statin Safety Update

The National Lipid Association (NLA) recently convened an Expert Panel on Statin Safety to examine various aspects of statin therapy and to determine its safety, patient tolerance and effectiveness.

Statin Safety 2014 Update

National Lipid Association Statement Regarding Reporting of Non-HDL on Standard Laboratory Reports

Click here to view the manuscript.

Adapted from an article in the Journal of Clinical Lipidology (JCL) titled, The Importance of Non-HDL Cholesterol Reporting in Lipid Management¹